CA2774173A1 - Micro-rna, autoantibody and protein markers for diagnosis of neuronal injury - Google Patents

Info

Publication number

CA2774173A1

CA2774173A1 CA2774173A CA2774173A CA2774173A1 CA 2774173 A1 CA2774173 A1 CA 2774173A1 CA 2774173 A CA2774173 A CA 2774173A CA 2774173 A CA2774173 A CA 2774173A CA 2774173 A1 CA2774173 A1 CA 2774173A1

Authority

CA

Canada

Prior art keywords

biomarker

gfap

mir

tau

terminal

Prior art date

2009-09-14

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 108090000623 proteins and genes Proteins 0.000 title claims abstract description 107
• 102000004169 proteins and genes Human genes 0.000 title claims abstract description 106
• 108091070501 miRNA Proteins 0.000 title claims abstract description 47
• 208000014674 injury Diseases 0.000 title claims description 111
• 230000006378 damage Effects 0.000 title claims description 109
• 208000027418 Wounds and injury Diseases 0.000 title claims description 104
• 238000003745 diagnosis Methods 0.000 title abstract description 8
• 230000001537 neural effect Effects 0.000 title description 28
• 239000000090 biomarker Substances 0.000 claims abstract description 257
• 238000000034 method Methods 0.000 claims abstract description 131
• 208000030886 Traumatic Brain injury Diseases 0.000 claims abstract description 125
• 230000009529 traumatic brain injury Effects 0.000 claims abstract description 121
• 101710193519 Glial fibrillary acidic protein Proteins 0.000 claims abstract description 117
• 102100039289 Glial fibrillary acidic protein Human genes 0.000 claims abstract description 117
• 239000012472 biological sample Substances 0.000 claims abstract description 94
• 210000002966 serum Anatomy 0.000 claims abstract description 91
• 239000002679 microRNA Substances 0.000 claims abstract description 67
• 230000015556 catabolic process Effects 0.000 claims abstract description 64
• 230000008569 process Effects 0.000 claims abstract description 55
• 238000001514 detection method Methods 0.000 claims abstract description 54
• 210000001175 cerebrospinal fluid Anatomy 0.000 claims abstract description 50
• 210000002381 plasma Anatomy 0.000 claims abstract description 33
• 210000004369 blood Anatomy 0.000 claims abstract description 27
• 239000008280 blood Substances 0.000 claims abstract description 27
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 26
• 208000029028 brain injury Diseases 0.000 claims abstract description 25
• 201000010099 disease Diseases 0.000 claims abstract description 25
• 208000006011 Stroke Diseases 0.000 claims abstract description 14
• 208000037890 multiple organ injury Diseases 0.000 claims abstract description 7
• 208000004051 Chronic Traumatic Encephalopathy Diseases 0.000 claims abstract description 6
• 208000017004 dementia pugilistica Diseases 0.000 claims abstract description 6
• 210000005046 glial fibrillary acidic protein Anatomy 0.000 claims description 116
• 102000013498 tau Proteins Human genes 0.000 claims description 70
• 108010026424 tau Proteins Proteins 0.000 claims description 70
• 239000003795 chemical substances by application Substances 0.000 claims description 58
• 230000000926 neurological effect Effects 0.000 claims description 55
• 150000001413 amino acids Chemical class 0.000 claims description 47
• 238000003776 cleavage reaction Methods 0.000 claims description 47
• 210000004027 cell Anatomy 0.000 claims description 46
• 230000007017 scission Effects 0.000 claims description 46
• 210000002569 neuron Anatomy 0.000 claims description 38
• 102000039446 nucleic acids Human genes 0.000 claims description 37
• 108020004707 nucleic acids Proteins 0.000 claims description 37
• 150000007523 nucleic acids Chemical group 0.000 claims description 37
• 210000001519 tissue Anatomy 0.000 claims description 26
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 25
• 230000014509 gene expression Effects 0.000 claims description 23
• 210000004899 c-terminal region Anatomy 0.000 claims description 22
• 101000891579 Homo sapiens Microtubule-associated protein tau Proteins 0.000 claims description 19
• 230000027455 binding Effects 0.000 claims description 17
• 102000057063 human MAPT Human genes 0.000 claims description 17
• 230000004044 response Effects 0.000 claims description 17
• 108010022181 Phosphopyruvate Hydratase Proteins 0.000 claims description 14
• 102000012338 Poly(ADP-ribose) Polymerases Human genes 0.000 claims description 14
• 108010061844 Poly(ADP-ribose) Polymerases Proteins 0.000 claims description 14
• 229920000776 Poly(Adenosine diphosphate-ribose) polymerase Polymers 0.000 claims description 14
• 101100480719 Rattus norvegicus Mapt gene Proteins 0.000 claims description 14
• 150000001875 compounds Chemical class 0.000 claims description 14
• 102100035037 Calpastatin Human genes 0.000 claims description 13
• 108010044208 calpastatin Proteins 0.000 claims description 13
• 101000979001 Homo sapiens Methionine aminopeptidase 2 Proteins 0.000 claims description 12
• 101000969087 Homo sapiens Microtubule-associated protein 2 Proteins 0.000 claims description 12
• 102000009664 Microtubule-Associated Proteins Human genes 0.000 claims description 12
• 108010020004 Microtubule-Associated Proteins Proteins 0.000 claims description 12
• 102100021118 Microtubule-associated protein 2 Human genes 0.000 claims description 12
• 102100035414 Neurofascin Human genes 0.000 claims description 12
• 101710189786 Neurofascin Proteins 0.000 claims description 12
• 230000004770 neurodegeneration Effects 0.000 claims description 12
• 230000015572 biosynthetic process Effects 0.000 claims description 10
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 10
• 210000003296 saliva Anatomy 0.000 claims description 10
• 210000002700 urine Anatomy 0.000 claims description 10
• 108090000371 Esterases Proteins 0.000 claims description 9
• 102000013008 Semaphorin-3A Human genes 0.000 claims description 9
• 108010090319 Semaphorin-3A Proteins 0.000 claims description 9
• 108090000848 Ubiquitin Proteins 0.000 claims description 9
• 102000044159 Ubiquitin Human genes 0.000 claims description 9
• 208000015122 neurodegenerative disease Diseases 0.000 claims description 9
• 102000008880 Peptidase C12, ubiquitin carboxyl-terminal hydrolases Human genes 0.000 claims description 8
• 108050000823 Peptidase C12, ubiquitin carboxyl-terminal hydrolases Proteins 0.000 claims description 8
• 108010055170 Synaptotagmin I Proteins 0.000 claims description 7
• 102100036417 Synaptotagmin-1 Human genes 0.000 claims description 7
• 230000003834 intracellular effect Effects 0.000 claims description 7
• 108050002656 Dihydropyrimidinase-related protein 1 Proteins 0.000 claims description 6
• 102100022188 Dihydropyrimidinase-related protein 1 Human genes 0.000 claims description 6
• 101000888419 Homo sapiens Glial fibrillary acidic protein Proteins 0.000 claims description 6
• 102100023057 Neurofilament light polypeptide Human genes 0.000 claims description 6
• 102100037591 Neuroserpin Human genes 0.000 claims description 6
• 102000051520 human GFAP Human genes 0.000 claims description 6
• 108010080874 neuroserpin Proteins 0.000 claims description 6
• 238000003786 synthesis reaction Methods 0.000 claims description 6
• 102100024075 Alpha-internexin Human genes 0.000 claims description 5
• 108091080995 Mir-9/mir-79 microRNA precursor family Proteins 0.000 claims description 5
• 108010065472 Vimentin Proteins 0.000 claims description 5
• 102000003734 Voltage-Gated Potassium Channels Human genes 0.000 claims description 5
• 108090000013 Voltage-Gated Potassium Channels Proteins 0.000 claims description 5
• 108010011385 alpha-internexin Proteins 0.000 claims description 5
• ZXJCOYBPXOBJMU-HSQGJUDPSA-N calpastatin peptide Ac 184-210 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(O)=O)NC(C)=O)[C@@H](C)O)C1=CC=C(O)C=C1 ZXJCOYBPXOBJMU-HSQGJUDPSA-N 0.000 claims description 5
• 210000005049 internexin Anatomy 0.000 claims description 5
• 108091047084 miR-9 stem-loop Proteins 0.000 claims description 5
• 102000003137 synaptotagmin Human genes 0.000 claims description 5
• 108060008004 synaptotagmin Proteins 0.000 claims description 5
• 210000005048 vimentin Anatomy 0.000 claims description 5
• 108091006112 ATPases Proteins 0.000 claims description 4
• 102000057290 Adenosine Triphosphatases Human genes 0.000 claims description 4
• 102100023206 Neuromodulin Human genes 0.000 claims description 4
• 101710144282 Neuromodulin Proteins 0.000 claims description 4
• 102000004874 Synaptophysin Human genes 0.000 claims description 4
• 108090001076 Synaptophysin Proteins 0.000 claims description 4
• 108091043249 miR-135-1 stem-loop Proteins 0.000 claims description 4
• 108091064876 miR-135-2 stem-loop Proteins 0.000 claims description 4
• 229920001184 polypeptide Polymers 0.000 claims description 4
• 102100025172 Calpain-1 catalytic subunit Human genes 0.000 claims description 3
• 102100028410 Endophilin-A1 Human genes 0.000 claims description 3
• 101710197301 Endophilin-A1 Proteins 0.000 claims description 3
• 101000934069 Homo sapiens Calpain-1 catalytic subunit Proteins 0.000 claims description 3
• 108091028049 Mir-221 microRNA Proteins 0.000 claims description 3
• 102100030610 Mothers against decapentaplegic homolog 5 Human genes 0.000 claims description 3
• 101710143113 Mothers against decapentaplegic homolog 5 Proteins 0.000 claims description 3
• 102000017299 Synapsin-1 Human genes 0.000 claims description 3
• 108050005241 Synapsin-1 Proteins 0.000 claims description 3
• 102000004243 Tubulin Human genes 0.000 claims description 3
• 108090000704 Tubulin Proteins 0.000 claims description 3
• 108091080321 miR-222 stem-loop Proteins 0.000 claims description 3
• 108091074487 miR-34 stem-loop Proteins 0.000 claims description 3
• 108091092493 miR-34-1 stem-loop Proteins 0.000 claims description 3
• 108091059780 miR-34-2 stem-loop Proteins 0.000 claims description 3
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 3
• 102000000568 rho-Associated Kinases Human genes 0.000 claims description 3
• 108010041788 rho-Associated Kinases Proteins 0.000 claims description 3
• 102000007372 Ataxin-1 Human genes 0.000 claims description 2
• 108010032963 Ataxin-1 Proteins 0.000 claims description 2
• 101000673946 Homo sapiens Synaptotagmin-like protein 1 Proteins 0.000 claims description 2
• 102100025087 Insulin receptor substrate 1 Human genes 0.000 claims description 2
• 101710201824 Insulin receptor substrate 1 Proteins 0.000 claims description 2
• 108091028080 MiR-132 Proteins 0.000 claims description 2
• 108091027966 Mir-137 Proteins 0.000 claims description 2
• 102100040541 Synaptotagmin-like protein 1 Human genes 0.000 claims description 2
• 102000017392 Syntaphilin Human genes 0.000 claims description 2
• 108050005502 Syntaphilin Proteins 0.000 claims description 2
• 108091055434 miR-124a stem-loop Proteins 0.000 claims description 2
• 108091082871 miR-124a-2 stem-loop Proteins 0.000 claims description 2
• 108091050112 miR-124a-4 stem-loop Proteins 0.000 claims description 2
• 108091054623 miR-124a-5 stem-loop Proteins 0.000 claims description 2
• 108091024680 miR-124a-6 stem-loop Proteins 0.000 claims description 2
• 108091024609 miR-124b stem-loop Proteins 0.000 claims description 2
• 108091081188 miR-124b-1 stem-loop Proteins 0.000 claims description 2
• 108091060300 miR-124b-2 stem-loop Proteins 0.000 claims description 2
• 108091044988 miR-125a stem-loop Proteins 0.000 claims description 2
• 108091049513 miR-125a-1 stem-loop Proteins 0.000 claims description 2
• 108091040046 miR-125a-2 stem-loop Proteins 0.000 claims description 2
• 108091091360 miR-125b stem-loop Proteins 0.000 claims description 2
• 108091070946 miR-128 stem-loop Proteins 0.000 claims description 2
• 108091029379 miR-139 stem-loop Proteins 0.000 claims description 2
• 108091033783 miR-153 stem-loop Proteins 0.000 claims description 2
• 108091029500 miR-183 stem-loop Proteins 0.000 claims description 2
• 108091058965 miR-218a stem-loop Proteins 0.000 claims description 2
• 108091063841 miR-219 stem-loop Proteins 0.000 claims description 2
• 108091038507 miR-92b stem-loop Proteins 0.000 claims description 2
• 108091081014 miR-92b-1 stem-loop Proteins 0.000 claims description 2
• 108091032846 miR-92b-2 stem loop Proteins 0.000 claims description 2
• 125000003275 alpha amino acid group Chemical group 0.000 claims 8
• 102100028652 Gamma-enolase Human genes 0.000 claims 4
• 102000013127 Vimentin Human genes 0.000 claims 2
• 210000004556 brain Anatomy 0.000 abstract description 61
• 239000000463 material Substances 0.000 abstract description 12
• 230000001154 acute effect Effects 0.000 abstract description 6
• 230000002797 proteolythic effect Effects 0.000 abstract description 3
• 231100000878 neurological injury Toxicity 0.000 abstract description 2
• 208000000532 Chronic Brain Injury Diseases 0.000 abstract 1
• 241000282414 Homo sapiens Species 0.000 description 94
• 235000018102 proteins Nutrition 0.000 description 89
• 102000007590 Calpain Human genes 0.000 description 77
• 108010032088 Calpain Proteins 0.000 description 77
• 241000700159 Rattus Species 0.000 description 65
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 46
• 102000011727 Caspases Human genes 0.000 description 45
• 108010076667 Caspases Proteins 0.000 description 45
• 239000000523 sample Substances 0.000 description 44
• 239000000047 product Substances 0.000 description 42
• 101000759926 Homo sapiens Ubiquitin carboxyl-terminal hydrolase isozyme L1 Proteins 0.000 description 38
• 102100025038 Ubiquitin carboxyl-terminal hydrolase isozyme L1 Human genes 0.000 description 37
• 239000000427 antigen Substances 0.000 description 31
• 108091007433 antigens Proteins 0.000 description 31
• 102000036639 antigens Human genes 0.000 description 31
• 230000001965 increasing effect Effects 0.000 description 28
• 102000053602 DNA Human genes 0.000 description 27
• 108020004414 DNA Proteins 0.000 description 27
• 230000001404 mediated effect Effects 0.000 description 27
• 230000001225 therapeutic effect Effects 0.000 description 25
• 238000003556 assay Methods 0.000 description 24
• 239000012634 fragment Substances 0.000 description 23
• 238000001262 western blot Methods 0.000 description 23
• 238000012360 testing method Methods 0.000 description 22
• 239000006166 lysate Substances 0.000 description 21
• 238000011282 treatment Methods 0.000 description 20
• 108090000397 Caspase 3 Proteins 0.000 description 19
• 102000003952 Caspase 3 Human genes 0.000 description 19
• 235000001014 amino acid Nutrition 0.000 description 19
• 239000003550 marker Substances 0.000 description 19
• 239000000758 substrate Substances 0.000 description 19
• 108700011259 MicroRNAs Proteins 0.000 description 17
• 206010008089 Cerebral artery occlusion Diseases 0.000 description 16
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 16
• 241001465754 Metazoa Species 0.000 description 16
• 229940024606 amino acid Drugs 0.000 description 16
• 238000004458 analytical method Methods 0.000 description 16
• 230000006907 apoptotic process Effects 0.000 description 16
• 229960001484 edetic acid Drugs 0.000 description 16
• 230000000694 effects Effects 0.000 description 16
• 201000007309 middle cerebral artery infarction Diseases 0.000 description 16
• KISWVXRQTGLFGD-UHFFFAOYSA-N 2-[[2-[[6-amino-2-[[2-[[2-[[5-amino-2-[[2-[[1-[2-[[6-amino-2-[(2,5-diamino-5-oxopentanoyl)amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-(diaminomethylideneamino)p Chemical compound C1CCN(C(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)NC(=O)C(N)CCC(N)=O)C1C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 KISWVXRQTGLFGD-UHFFFAOYSA-N 0.000 description 15
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 15
• 230000006870 function Effects 0.000 description 15
• 230000017854 proteolysis Effects 0.000 description 15
• 102000047918 Myelin Basic Human genes 0.000 description 14
• 101710107068 Myelin basic protein Proteins 0.000 description 14
• 102000003900 Calpain-2 Human genes 0.000 description 12
• 108090000232 Calpain-2 Proteins 0.000 description 12
• 239000002033 PVDF binder Substances 0.000 description 12
• 102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 12
• 230000004913 activation Effects 0.000 description 12
• 238000005259 measurement Methods 0.000 description 12
• 230000007246 mechanism Effects 0.000 description 12
• 229920002981 polyvinylidene fluoride Polymers 0.000 description 12
• 208000024827 Alzheimer disease Diseases 0.000 description 11
• 102000003895 Calpain-1 Human genes 0.000 description 11
• 108090000236 Calpain-1 Proteins 0.000 description 11
• 239000003153 chemical reaction reagent Substances 0.000 description 11
• 239000003814 drug Substances 0.000 description 11
• 238000000338 in vitro Methods 0.000 description 11
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 11
• 238000002965 ELISA Methods 0.000 description 10
• -1 all-spectrin Proteins 0.000 description 10
• 239000013060 biological fluid Substances 0.000 description 10
• HKSZLNNOFSGOKW-UHFFFAOYSA-N ent-staurosporine Natural products C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1C1CC(NC)C(OC)C4(C)O1 HKSZLNNOFSGOKW-UHFFFAOYSA-N 0.000 description 10
• 239000012528 membrane Substances 0.000 description 10
• 108020004999 messenger RNA Proteins 0.000 description 10
• HKSZLNNOFSGOKW-FYTWVXJKSA-N staurosporine Chemical compound C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1[C@H]1C[C@@H](NC)[C@@H](OC)[C@]4(C)O1 HKSZLNNOFSGOKW-FYTWVXJKSA-N 0.000 description 10
• CGPUWJWCVCFERF-UHFFFAOYSA-N staurosporine Natural products C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1C1CC(NC)C(OC)C4(OC)O1 CGPUWJWCVCFERF-UHFFFAOYSA-N 0.000 description 10
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
• HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 description 9
• 241000283973 Oryctolagus cuniculus Species 0.000 description 9
• 108010079785 calpain inhibitors Proteins 0.000 description 9
• 210000003169 central nervous system Anatomy 0.000 description 9
• 239000012530 fluid Substances 0.000 description 9
• 239000000499 gel Substances 0.000 description 9
• 210000001320 hippocampus Anatomy 0.000 description 9
• 239000000203 mixture Substances 0.000 description 9
• 230000004083 survival effect Effects 0.000 description 9
• 229940121926 Calpain inhibitor Drugs 0.000 description 8
• 102000035195 Peptidases Human genes 0.000 description 8
• 108091005804 Peptidases Proteins 0.000 description 8
• 108010019965 Spectrin Proteins 0.000 description 8
• 102000005890 Spectrin Human genes 0.000 description 8
• VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 8
• 230000029087 digestion Effects 0.000 description 8
• 238000001727 in vivo Methods 0.000 description 8
• 210000000056 organ Anatomy 0.000 description 8
• 238000003753 real-time PCR Methods 0.000 description 8
• 239000000126 substance Substances 0.000 description 8
• 238000002560 therapeutic procedure Methods 0.000 description 8
• PMEQLUMDXFJNRY-SFTDATJTSA-N 2-(2-methoxyethoxy)ethyl n-[(2s)-1-[[(2s)-4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamate Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)OCCOCCOC)C(=O)C(=O)NC1CC1)C1=CC=CC=C1 PMEQLUMDXFJNRY-SFTDATJTSA-N 0.000 description 7
• 108010009685 Cholinergic Receptors Proteins 0.000 description 7
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 7
• 239000004365 Protease Substances 0.000 description 7
• 102000034337 acetylcholine receptors Human genes 0.000 description 7
• 230000001413 cellular effect Effects 0.000 description 7
• 230000008859 change Effects 0.000 description 7
• 230000001054 cortical effect Effects 0.000 description 7
• 238000002474 experimental method Methods 0.000 description 7
• 229960000485 methotrexate Drugs 0.000 description 7
• 230000003551 muscarinic effect Effects 0.000 description 7
• 230000007170 pathology Effects 0.000 description 7
• 238000003752 polymerase chain reaction Methods 0.000 description 7
• 238000011160 research Methods 0.000 description 7
• 230000002123 temporal effect Effects 0.000 description 7
• 230000008733 trauma Effects 0.000 description 7
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
• 102100040458 2',3'-cyclic-nucleotide 3'-phosphodiesterase Human genes 0.000 description 6
• 108091023037 Aptamer Proteins 0.000 description 6
• 101001092197 Homo sapiens RNA binding protein fox-1 homolog 3 Proteins 0.000 description 6
• 102100040243 Microtubule-associated protein tau Human genes 0.000 description 6
• 101710115937 Microtubule-associated protein tau Proteins 0.000 description 6
• 108091034117 Oligonucleotide Proteins 0.000 description 6
• 108010029485 Protein Isoforms Proteins 0.000 description 6
• 102000001708 Protein Isoforms Human genes 0.000 description 6
• 102100035530 RNA binding protein fox-1 homolog 3 Human genes 0.000 description 6
• 230000005856 abnormality Effects 0.000 description 6
• OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 6
• 239000000556 agonist Substances 0.000 description 6
• 239000005557 antagonist Substances 0.000 description 6
• 230000001640 apoptogenic effect Effects 0.000 description 6
• 230000003376 axonal effect Effects 0.000 description 6
• 230000008901 benefit Effects 0.000 description 6
• 238000002512 chemotherapy Methods 0.000 description 6
• 230000018109 developmental process Effects 0.000 description 6
• 230000003447 ipsilateral effect Effects 0.000 description 6
• 230000017074 necrotic cell death Effects 0.000 description 6
• 210000000653 nervous system Anatomy 0.000 description 6
• 230000037361 pathway Effects 0.000 description 6
• 238000012216 screening Methods 0.000 description 6
• 238000001356 surgical procedure Methods 0.000 description 6
• 238000005406 washing Methods 0.000 description 6
• QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 5
• 241000282412 Homo Species 0.000 description 5
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 5
• PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 5
• 102000011779 Nitric Oxide Synthase Type II Human genes 0.000 description 5
• 108010076864 Nitric Oxide Synthase Type II Proteins 0.000 description 5
• 108091000054 Prion Proteins 0.000 description 5
• 230000033228 biological regulation Effects 0.000 description 5
• 230000006931 brain damage Effects 0.000 description 5
• 210000005013 brain tissue Anatomy 0.000 description 5
• 230000005779 cell damage Effects 0.000 description 5
• 230000030833 cell death Effects 0.000 description 5
• 238000002591 computed tomography Methods 0.000 description 5
• 230000003247 decreasing effect Effects 0.000 description 5
• 238000011161 development Methods 0.000 description 5
• 238000013467 fragmentation Methods 0.000 description 5
• 238000006062 fragmentation reaction Methods 0.000 description 5
• 239000000411 inducer Substances 0.000 description 5
• 230000005764 inhibitory process Effects 0.000 description 5
• 229960002725 isoflurane Drugs 0.000 description 5
• 238000004519 manufacturing process Methods 0.000 description 5
• 238000004949 mass spectrometry Methods 0.000 description 5
• 230000001575 pathological effect Effects 0.000 description 5
• 238000010647 peptide synthesis reaction Methods 0.000 description 5
• 239000012071 phase Substances 0.000 description 5
• 235000019419 proteases Nutrition 0.000 description 5
• 238000011002 quantification Methods 0.000 description 5
• 239000007787 solid Substances 0.000 description 5
• 241000894007 species Species 0.000 description 5
• 230000000472 traumatic effect Effects 0.000 description 5
• 239000003656 tris buffered saline Substances 0.000 description 5
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
• 108010022794 2',3'-Cyclic-Nucleotide Phosphodiesterases Proteins 0.000 description 4
• SHXWCVYOXRDMCX-UHFFFAOYSA-N 3,4-methylenedioxymethamphetamine Chemical compound CNC(C)CC1=CC=C2OCOC2=C1 SHXWCVYOXRDMCX-UHFFFAOYSA-N 0.000 description 4
• 208000007333 Brain Concussion Diseases 0.000 description 4
• 102100024426 Dihydropyrimidinase-related protein 2 Human genes 0.000 description 4
• 108050002467 Dihydropyrimidinase-related protein 2 Proteins 0.000 description 4
• 102000004190 Enzymes Human genes 0.000 description 4
• 108090000790 Enzymes Proteins 0.000 description 4
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
• 101000574396 Homo sapiens Protein phosphatase 1K, mitochondrial Proteins 0.000 description 4
• 102000006386 Myelin Proteins Human genes 0.000 description 4
• 108010083674 Myelin Proteins Proteins 0.000 description 4
• 206010028851 Necrosis Diseases 0.000 description 4
• 102000008730 Nestin Human genes 0.000 description 4
• 108010088225 Nestin Proteins 0.000 description 4
• 102100025799 Protein phosphatase 1K, mitochondrial Human genes 0.000 description 4
• 230000004570 RNA-binding Effects 0.000 description 4
• 102100030986 Transgelin-3 Human genes 0.000 description 4
• 230000002159 abnormal effect Effects 0.000 description 4
• 238000002835 absorbance Methods 0.000 description 4
• 229960004373 acetylcholine Drugs 0.000 description 4
• 230000004075 alteration Effects 0.000 description 4
• 210000001130 astrocyte Anatomy 0.000 description 4
• 238000001574 biopsy Methods 0.000 description 4
• 231100000874 brain damage Toxicity 0.000 description 4
• 208000037887 cell injury Diseases 0.000 description 4
• 239000002299 complementary DNA Substances 0.000 description 4
• 230000002596 correlated effect Effects 0.000 description 4
• 230000008878 coupling Effects 0.000 description 4
• 238000010168 coupling process Methods 0.000 description 4
• 238000005859 coupling reaction Methods 0.000 description 4
• 230000007423 decrease Effects 0.000 description 4
• 230000001419 dependent effect Effects 0.000 description 4
• 206010015037 epilepsy Diseases 0.000 description 4
• 238000011156 evaluation Methods 0.000 description 4
• 230000002349 favourable effect Effects 0.000 description 4
• 108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 4
• 238000007726 management method Methods 0.000 description 4
• 210000005012 myelin Anatomy 0.000 description 4
• 210000005055 nestin Anatomy 0.000 description 4
• 108010090677 neurofilament protein L Proteins 0.000 description 4
• 210000004498 neuroglial cell Anatomy 0.000 description 4
• 230000007823 neuropathy Effects 0.000 description 4
• 201000001119 neuropathy Diseases 0.000 description 4
• 208000033808 peripheral neuropathy Diseases 0.000 description 4
• 239000002953 phosphate buffered saline Substances 0.000 description 4
• 230000002829 reductive effect Effects 0.000 description 4
• 230000035945 sensitivity Effects 0.000 description 4
• 102100034452 Alternative prion protein Human genes 0.000 description 3
• 241000283707 Capra Species 0.000 description 3
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 3
• 229940123169 Caspase inhibitor Drugs 0.000 description 3
• 230000004568 DNA-binding Effects 0.000 description 3
• 102100024441 Dihydropyrimidinase-related protein 5 Human genes 0.000 description 3
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
• 101000578830 Homo sapiens Methionine aminopeptidase 1 Proteins 0.000 description 3
• 101001057324 Homo sapiens Microtubule-associated protein 1A Proteins 0.000 description 3
• 208000032382 Ischaemic stroke Diseases 0.000 description 3
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
• 102100028379 Methionine aminopeptidase 1 Human genes 0.000 description 3
• 241000699666 Mus <mouse, genus> Species 0.000 description 3
• 108050003473 Muscarinic acetylcholine receptor Proteins 0.000 description 3
• 102000014415 Muscarinic acetylcholine receptor Human genes 0.000 description 3
• 206010028980 Neoplasm Diseases 0.000 description 3
• 206010048705 Paraneoplastic cerebellar degeneration Diseases 0.000 description 3
• 102100028465 Peripherin Human genes 0.000 description 3
• 108010003081 Peripherins Proteins 0.000 description 3
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
• 239000007983 Tris buffer Substances 0.000 description 3
• 102100035071 Vimentin Human genes 0.000 description 3
• 230000032683 aging Effects 0.000 description 3
• 238000010171 animal model Methods 0.000 description 3
• 210000003050 axon Anatomy 0.000 description 3
• 230000003542 behavioural effect Effects 0.000 description 3
• 239000011616 biotin Substances 0.000 description 3
• 229960002685 biotin Drugs 0.000 description 3
• 235000020958 biotin Nutrition 0.000 description 3
• 239000000872 buffer Substances 0.000 description 3
• 235000011089 carbon dioxide Nutrition 0.000 description 3
• 238000005119 centrifugation Methods 0.000 description 3
• 238000004891 communication Methods 0.000 description 3
• 230000009260 cross reactivity Effects 0.000 description 3
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 3
• 238000006731 degradation reaction Methods 0.000 description 3
• 230000003111 delayed effect Effects 0.000 description 3
• 238000013461 design Methods 0.000 description 3
• 238000010790 dilution Methods 0.000 description 3
• 239000012895 dilution Substances 0.000 description 3
• 229940000406 drug candidate Drugs 0.000 description 3
• 238000009509 drug development Methods 0.000 description 3
• 238000001914 filtration Methods 0.000 description 3
• 230000036541 health Effects 0.000 description 3
• 230000002519 immonomodulatory effect Effects 0.000 description 3
• 238000003119 immunoblot Methods 0.000 description 3
• 238000001114 immunoprecipitation Methods 0.000 description 3
• 238000011534 incubation Methods 0.000 description 3
• 230000000302 ischemic effect Effects 0.000 description 3
• 230000004807 localization Effects 0.000 description 3
• 210000003061 neural cell Anatomy 0.000 description 3
• 210000002682 neurofibrillary tangle Anatomy 0.000 description 3
• 231100000189 neurotoxic Toxicity 0.000 description 3
• 230000002887 neurotoxic effect Effects 0.000 description 3
• 125000003729 nucleotide group Chemical group 0.000 description 3
• 239000000137 peptide hydrolase inhibitor Substances 0.000 description 3
• 210000001428 peripheral nervous system Anatomy 0.000 description 3
• 210000005047 peripherin Anatomy 0.000 description 3
• 230000000144 pharmacologic effect Effects 0.000 description 3
• 238000001742 protein purification Methods 0.000 description 3
• 238000012163 sequencing technique Methods 0.000 description 3
• 238000010186 staining Methods 0.000 description 3
• 238000012546 transfer Methods 0.000 description 3
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
• 108010041801 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase Proteins 0.000 description 2
• QRXMUCSWCMTJGU-UHFFFAOYSA-N 5-bromo-4-chloro-3-indolyl phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP(O)(=O)O)=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-N 0.000 description 2
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
• 108010090849 Amyloid beta-Peptides Proteins 0.000 description 2
• 102000013455 Amyloid beta-Peptides Human genes 0.000 description 2
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
• 108091032955 Bacterial small RNA Proteins 0.000 description 2
• 208000013883 Blast injury Diseases 0.000 description 2
• 108050007957 Cadherin Proteins 0.000 description 2
• 102000000905 Cadherin Human genes 0.000 description 2
• 102100029184 Calmodulin regulator protein PCP4 Human genes 0.000 description 2
• 102000018208 Cannabinoid Receptor Human genes 0.000 description 2
• 108050007331 Cannabinoid receptor Proteins 0.000 description 2
• 102100036214 Cannabinoid receptor 2 Human genes 0.000 description 2
• 101710187022 Cannabinoid receptor 2 Proteins 0.000 description 2
• 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 2
• 206010008025 Cerebellar ataxia Diseases 0.000 description 2
• 206010012289 Dementia Diseases 0.000 description 2
• 208000032131 Diabetic Neuropathies Diseases 0.000 description 2
• 208000000202 Diffuse Axonal Injury Diseases 0.000 description 2
• 102100021238 Dynamin-2 Human genes 0.000 description 2
• 240000003537 Ficus benghalensis Species 0.000 description 2
• 108010072051 Glatiramer Acetate Proteins 0.000 description 2
• 108010027915 Glutamate Receptors Proteins 0.000 description 2
• 102000018899 Glutamate Receptors Human genes 0.000 description 2
• 102000008214 Glutamate decarboxylase Human genes 0.000 description 2
• 108091022930 Glutamate decarboxylase Proteins 0.000 description 2
• 239000004471 Glycine Substances 0.000 description 2
• 206010019196 Head injury Diseases 0.000 description 2
• 101001053479 Homo sapiens Dihydropyrimidinase-related protein 5 Proteins 0.000 description 2
• 101000817607 Homo sapiens Dynamin-2 Proteins 0.000 description 2
• 101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 description 2
• 101000652720 Homo sapiens Transgelin-3 Proteins 0.000 description 2
• 208000004454 Hyperalgesia Diseases 0.000 description 2
• 108060003951 Immunoglobulin Proteins 0.000 description 2
• 108090001005 Interleukin-6 Proteins 0.000 description 2
• 201000010743 Lambert-Eaton myasthenic syndrome Diseases 0.000 description 2
• 206010028424 Myasthenic syndrome Diseases 0.000 description 2
• SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
• 108050000637 N-cadherin Proteins 0.000 description 2
• 102000008763 Neurofilament Proteins Human genes 0.000 description 2
• 108010088373 Neurofilament Proteins Proteins 0.000 description 2
• 102100024007 Neurofilament heavy polypeptide Human genes 0.000 description 2
• 101710159895 Neurofilament heavy polypeptide Proteins 0.000 description 2
• 102100023055 Neurofilament medium polypeptide Human genes 0.000 description 2
• 101710109612 Neurofilament medium polypeptide Proteins 0.000 description 2
• 206010072359 Neuromyotonia Diseases 0.000 description 2
• 208000017787 Paraneoplastic neurologic syndrome Diseases 0.000 description 2
• 208000018737 Parkinson disease Diseases 0.000 description 2
• 241001494479 Pecora Species 0.000 description 2
• 108091036407 Polyadenylation Proteins 0.000 description 2
• 229920001213 Polysorbate 20 Polymers 0.000 description 2
• 102000029797 Prion Human genes 0.000 description 2
• 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 2
• 101000746366 Rattus norvegicus Granulocyte-macrophage colony-stimulating factor Proteins 0.000 description 2
• 241000283984 Rodentia Species 0.000 description 2
• 108091006629 SLC13A2 Proteins 0.000 description 2
• UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
• 206010072148 Stiff-Person syndrome Diseases 0.000 description 2
• 108010090804 Streptavidin Proteins 0.000 description 2
• 208000034799 Tauopathies Diseases 0.000 description 2
• 108050006165 Transgelin-3 Proteins 0.000 description 2
• 239000013504 Triton X-100 Substances 0.000 description 2
• 229920004890 Triton X-100 Polymers 0.000 description 2
• 102100029293 Tubby-related protein 1 Human genes 0.000 description 2
• 101710147826 Tubby-related protein 1 Proteins 0.000 description 2
• 206010053613 Type IV hypersensitivity reaction Diseases 0.000 description 2
• 108010005656 Ubiquitin Thiolesterase Proteins 0.000 description 2
• 102000005918 Ubiquitin Thiolesterase Human genes 0.000 description 2
• 238000009825 accumulation Methods 0.000 description 2
• FHEAIOHRHQGZPC-KIWGSFCNSA-N acetic acid;(2s)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2s)-2-aminopentanedioic acid;(2s)-2-aminopropanoic acid;(2s)-2,6-diaminohexanoic acid Chemical compound CC(O)=O.C[C@H](N)C(O)=O.NCCCC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CCC(O)=O.OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 FHEAIOHRHQGZPC-KIWGSFCNSA-N 0.000 description 2
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 2
• 238000000137 annealing Methods 0.000 description 2
• 238000013459 approach Methods 0.000 description 2
• HJJPJSXJAXAIPN-UHFFFAOYSA-N arecoline Chemical compound COC(=O)C1=CCCN(C)C1 HJJPJSXJAXAIPN-UHFFFAOYSA-N 0.000 description 2
• 230000001363 autoimmune Effects 0.000 description 2
• 230000007844 axonal damage Effects 0.000 description 2
• 239000011230 binding agent Substances 0.000 description 2
• 230000004071 biological effect Effects 0.000 description 2
• 239000012620 biological material Substances 0.000 description 2
• 230000000903 blocking effect Effects 0.000 description 2
• 230000017531 blood circulation Effects 0.000 description 2
• 210000001185 bone marrow Anatomy 0.000 description 2
• 201000011510 cancer Diseases 0.000 description 2
• 210000001168 carotid artery common Anatomy 0.000 description 2
• 239000012159 carrier gas Substances 0.000 description 2
• 210000000170 cell membrane Anatomy 0.000 description 2
• 230000002490 cerebral effect Effects 0.000 description 2
• 239000002738 chelating agent Substances 0.000 description 2
• 238000006243 chemical reaction Methods 0.000 description 2
• 230000001684 chronic effect Effects 0.000 description 2
• 230000007278 cognition impairment Effects 0.000 description 2
• 239000003431 cross linking reagent Substances 0.000 description 2
• 235000018417 cysteine Nutrition 0.000 description 2
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
• 210000000805 cytoplasm Anatomy 0.000 description 2
• 230000001086 cytosolic effect Effects 0.000 description 2
• 231100000433 cytotoxic Toxicity 0.000 description 2
• 230000001472 cytotoxic effect Effects 0.000 description 2
• 230000009521 diffuse axonal injury Effects 0.000 description 2
• 238000009826 distribution Methods 0.000 description 2
• 230000003828 downregulation Effects 0.000 description 2
• 229940079593 drug Drugs 0.000 description 2
• 230000009977 dual effect Effects 0.000 description 2
• 238000001962 electrophoresis Methods 0.000 description 2
• 231100000318 excitotoxic Toxicity 0.000 description 2
• 230000003492 excitotoxic effect Effects 0.000 description 2
• 235000013861 fat-free Nutrition 0.000 description 2
• 229960003776 glatiramer acetate Drugs 0.000 description 2
• 230000002518 glial effect Effects 0.000 description 2
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
• 210000003128 head Anatomy 0.000 description 2
• 238000010438 heat treatment Methods 0.000 description 2
• 238000004128 high performance liquid chromatography Methods 0.000 description 2
• 230000000971 hippocampal effect Effects 0.000 description 2
• 102000057986 human UCHL1 Human genes 0.000 description 2
• 238000003384 imaging method Methods 0.000 description 2
• 230000001900 immune effect Effects 0.000 description 2
• 238000003018 immunoassay Methods 0.000 description 2
• 102000018358 immunoglobulin Human genes 0.000 description 2
• 208000015181 infectious disease Diseases 0.000 description 2
• 239000003112 inhibitor Substances 0.000 description 2
• 238000002347 injection Methods 0.000 description 2
• 239000007924 injection Substances 0.000 description 2
• 238000002955 isolation Methods 0.000 description 2
• 238000002372 labelling Methods 0.000 description 2
• 230000000670 limiting effect Effects 0.000 description 2
• 229960001252 methamphetamine Drugs 0.000 description 2
• MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 2
• 238000002493 microarray Methods 0.000 description 2
• 210000000274 microglia Anatomy 0.000 description 2
• 230000009525 mild injury Effects 0.000 description 2
• 235000013336 milk Nutrition 0.000 description 2
• 239000008267 milk Substances 0.000 description 2
• 210000004080 milk Anatomy 0.000 description 2
• 230000004048 modification Effects 0.000 description 2
• 238000012986 modification Methods 0.000 description 2
• 201000006417 multiple sclerosis Diseases 0.000 description 2
• 210000003205 muscle Anatomy 0.000 description 2
• 230000035772 mutation Effects 0.000 description 2
• 230000007830 nerve conduction Effects 0.000 description 2
• 208000004296 neuralgia Diseases 0.000 description 2
• 230000001722 neurochemical effect Effects 0.000 description 2
• 230000003961 neuronal insult Effects 0.000 description 2
• 208000021722 neuropathic pain Diseases 0.000 description 2
• 239000002773 nucleotide Substances 0.000 description 2
• 230000000737 periodic effect Effects 0.000 description 2
• 230000002688 persistence Effects 0.000 description 2
• 230000026731 phosphorylation Effects 0.000 description 2
• 238000006366 phosphorylation reaction Methods 0.000 description 2
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
• 208000028173 post-traumatic stress disease Diseases 0.000 description 2
• 239000000843 powder Substances 0.000 description 2
• 238000002360 preparation method Methods 0.000 description 2
• 229940002612 prodrug Drugs 0.000 description 2
• 239000000651 prodrug Substances 0.000 description 2
• 210000000449 purkinje cell Anatomy 0.000 description 2
• 238000003127 radioimmunoassay Methods 0.000 description 2
• 102000005962 receptors Human genes 0.000 description 2
• 108020003175 receptors Proteins 0.000 description 2
• 238000011084 recovery Methods 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 230000003252 repetitive effect Effects 0.000 description 2
• 229920005989 resin Polymers 0.000 description 2
• 239000011347 resin Substances 0.000 description 2
• 230000002441 reversible effect Effects 0.000 description 2
• 238000012552 review Methods 0.000 description 2
• 206010039073 rheumatoid arthritis Diseases 0.000 description 2
• 238000005070 sampling Methods 0.000 description 2
• 208000037974 severe injury Diseases 0.000 description 2
• 230000009528 severe injury Effects 0.000 description 2
• 239000011780 sodium chloride Substances 0.000 description 2
• 239000000243 solution Substances 0.000 description 2
• 238000001228 spectrum Methods 0.000 description 2
• 230000035882 stress Effects 0.000 description 2
• 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 2
• 230000002459 sustained effect Effects 0.000 description 2
• 210000001550 testis Anatomy 0.000 description 2
• 230000001052 transient effect Effects 0.000 description 2
• 230000005951 type IV hypersensitivity Effects 0.000 description 2
• 208000027930 type IV hypersensitivity disease Diseases 0.000 description 2
• 210000004885 white matter Anatomy 0.000 description 2
• QCHFTSOMWOSFHM-WPRPVWTQSA-N (+)-Pilocarpine Chemical compound C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C QCHFTSOMWOSFHM-WPRPVWTQSA-N 0.000 description 1
• SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
• HONKEGXLWUDTCF-YFKPBYRVSA-N (2s)-2-amino-2-methyl-4-phosphonobutanoic acid Chemical compound OC(=O)[C@](N)(C)CCP(O)(O)=O HONKEGXLWUDTCF-YFKPBYRVSA-N 0.000 description 1
• QRXMUCSWCMTJGU-UHFFFAOYSA-L (5-bromo-4-chloro-1h-indol-3-yl) phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP([O-])(=O)[O-])=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-L 0.000 description 1
• QNRATNLHPGXHMA-XZHTYLCXSA-N (r)-(6-ethoxyquinolin-4-yl)-[(2s,4s,5r)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl]methanol;hydrochloride Chemical compound Cl.C([C@H]([C@H](C1)CC)C2)CN1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OCC)C=C21 QNRATNLHPGXHMA-XZHTYLCXSA-N 0.000 description 1
• MMUQVFDMUDOFSH-ONNFQVAWSA-N 1-azabicyclo[2.2.2]octan-3-yl (e)-2-hydroxy-5-iodo-2-phenylpent-4-enoate Chemical compound C1N(CC2)CCC2C1OC(=O)C(C\C=C\I)(O)C1=CC=CC=C1 MMUQVFDMUDOFSH-ONNFQVAWSA-N 0.000 description 1
• NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 description 1
• PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 1
• YRAJNWYBUCUFBD-UHFFFAOYSA-N 2,2,6,6-tetramethylheptane-3,5-dione Chemical compound CC(C)(C)C(=O)CC(=O)C(C)(C)C YRAJNWYBUCUFBD-UHFFFAOYSA-N 0.000 description 1
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
• 101150053137 AIF1 gene Proteins 0.000 description 1
• 102000003678 AMPA Receptors Human genes 0.000 description 1
• 108090000078 AMPA Receptors Proteins 0.000 description 1
• 102000015693 Actin Depolymerizing Factors Human genes 0.000 description 1
• 108010038798 Actin Depolymerizing Factors Proteins 0.000 description 1
• 108010088751 Albumins Proteins 0.000 description 1
• 102000009027 Albumins Human genes 0.000 description 1
• 102100026882 Alpha-synuclein Human genes 0.000 description 1
• 206010002091 Anaesthesia Diseases 0.000 description 1
• 102000012002 Aquaporin 4 Human genes 0.000 description 1
• 108010036280 Aquaporin 4 Proteins 0.000 description 1
• 208000032116 Autoimmune Experimental Encephalomyelitis Diseases 0.000 description 1
• 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 1
• 102000004072 Beclin-1 Human genes 0.000 description 1
• 108090000524 Beclin-1 Proteins 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
• 208000003174 Brain Neoplasms Diseases 0.000 description 1
• 208000014644 Brain disease Diseases 0.000 description 1
• 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 1
• 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 1
• 101150060249 CHRM3 gene Proteins 0.000 description 1
• 229940127291 Calcium channel antagonist Drugs 0.000 description 1
• 240000005589 Calophyllum inophyllum Species 0.000 description 1
• 241000700199 Cavia porcellus Species 0.000 description 1
• 102100035244 Cerebellin-1 Human genes 0.000 description 1
• 101710135505 Cerebellin-1 Proteins 0.000 description 1
• 206010008096 Cerebral atrophy Diseases 0.000 description 1
• 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
• 206010008513 Child maltreatment syndrome Diseases 0.000 description 1
• 206010008748 Chorea Diseases 0.000 description 1
• 101150073075 Chrm1 gene Proteins 0.000 description 1
• 101150012960 Chrm2 gene Proteins 0.000 description 1
• 108010044213 Class 5 Receptor-Like Protein Tyrosine Phosphatases Proteins 0.000 description 1
• 102000005853 Clathrin Human genes 0.000 description 1
• 108010019874 Clathrin Proteins 0.000 description 1
• 206010009944 Colon cancer Diseases 0.000 description 1
• 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
• 238000011537 Coomassie blue staining Methods 0.000 description 1
• 241000699800 Cricetinae Species 0.000 description 1
• 229930188353 Cyclostellettamine Natural products 0.000 description 1
• 102100030497 Cytochrome c Human genes 0.000 description 1
• 108010075031 Cytochromes c Proteins 0.000 description 1
• 101710088194 Dehydrogenase Proteins 0.000 description 1
• 206010012689 Diabetic retinopathy Diseases 0.000 description 1
• 102000011972 Dihydropyrimidinase-related protein 2 Human genes 0.000 description 1
• 102100024425 Dihydropyrimidinase-related protein 3 Human genes 0.000 description 1
• 108050002650 Dihydropyrimidinase-related protein 3 Proteins 0.000 description 1
• 108050002475 Dihydropyrimidinase-related protein 4 Proteins 0.000 description 1
• 102100024443 Dihydropyrimidinase-related protein 4 Human genes 0.000 description 1
• 108050002654 Dihydropyrimidinase-related protein 5 Proteins 0.000 description 1
• 244000236655 Diospyros kaki Species 0.000 description 1
• 235000008597 Diospyros kaki Nutrition 0.000 description 1
• 108700019745 Disks Large Homolog 4 Proteins 0.000 description 1
• 102000047174 Disks Large Homolog 4 Human genes 0.000 description 1
• 102100024117 Disks large homolog 2 Human genes 0.000 description 1
• 101710185758 Disks large homolog 2 Proteins 0.000 description 1
• 101100256637 Drosophila melanogaster senju gene Proteins 0.000 description 1
• 102000043859 Dynamin Human genes 0.000 description 1
• 108700021058 Dynamin Proteins 0.000 description 1
• 108010036694 Dynamin I Proteins 0.000 description 1
• 102100021236 Dynamin-1 Human genes 0.000 description 1
• 241000283074 Equus asinus Species 0.000 description 1
• 241000206602 Eukaryota Species 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• 101000941893 Felis catus Leucine-rich repeat and calponin homology domain-containing protein 1 Proteins 0.000 description 1
• 241000287828 Gallus gallus Species 0.000 description 1
• 101000984012 Gallus gallus Cadherin-1 Proteins 0.000 description 1
• 102000034575 Glutamate transporters Human genes 0.000 description 1
• 108091006151 Glutamate transporters Proteins 0.000 description 1
• 102000007390 Glycogen Phosphorylase Human genes 0.000 description 1
• 108010046163 Glycogen Phosphorylase Proteins 0.000 description 1
• 208000035895 Guillain-Barré syndrome Diseases 0.000 description 1
• 208000023329 Gun shot wound Diseases 0.000 description 1
• 208000010496 Heart Arrest Diseases 0.000 description 1
• FMPNFDSPHNUFOS-HQEQRHKESA-N Himbacine Natural products C(/[C@@H]1[C@H]2CCCC[C@@H]2C[C@@H]2C(=O)O[C@H]([C@H]12)C)=C\[C@@H]1CCC[C@H](C)N1C FMPNFDSPHNUFOS-HQEQRHKESA-N 0.000 description 1
• 102000010029 Homer Scaffolding Proteins Human genes 0.000 description 1
• 108010077223 Homer Scaffolding Proteins Proteins 0.000 description 1
• 101000988362 Homo sapiens Calmodulin regulator protein PCP4 Proteins 0.000 description 1
• 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 description 1
• 101000616438 Homo sapiens Microtubule-associated protein 4 Proteins 0.000 description 1
• 101000652332 Homo sapiens Transcription factor SOX-1 Proteins 0.000 description 1
• 108091070514 Homo sapiens let-7b stem-loop Proteins 0.000 description 1
• 108091070511 Homo sapiens let-7c stem-loop Proteins 0.000 description 1
• 108091069047 Homo sapiens let-7i stem-loop Proteins 0.000 description 1
• 108091045825 Homo sapiens miR-1181 stem-loop Proteins 0.000 description 1
• 108091044902 Homo sapiens miR-1202 stem-loop Proteins 0.000 description 1
• 108091060466 Homo sapiens miR-1224 stem-loop Proteins 0.000 description 1
• 108091044921 Homo sapiens miR-1225 stem-loop Proteins 0.000 description 1
• 108091044923 Homo sapiens miR-1226 stem-loop Proteins 0.000 description 1
• 108091044926 Homo sapiens miR-1227 stem-loop Proteins 0.000 description 1
• 108091044953 Homo sapiens miR-1228 stem-loop Proteins 0.000 description 1
• 108091044954 Homo sapiens miR-1229 stem-loop Proteins 0.000 description 1
• 108091044881 Homo sapiens miR-1246 stem-loop Proteins 0.000 description 1
• 108091069006 Homo sapiens miR-125b-1 stem-loop Proteins 0.000 description 1
• 108091069086 Homo sapiens miR-127 stem-loop Proteins 0.000 description 1
• 108091044777 Homo sapiens miR-1275 stem-loop Proteins 0.000 description 1
• 108091044796 Homo sapiens miR-1290 stem-loop Proteins 0.000 description 1
• 108091060453 Homo sapiens miR-1296 stem-loop Proteins 0.000 description 1
• 108091064864 Homo sapiens miR-1470 stem-loop Proteins 0.000 description 1
• 108091078084 Homo sapiens miR-1825 stem-loop Proteins 0.000 description 1
• 108091068954 Homo sapiens miR-185 stem-loop Proteins 0.000 description 1
• 108091079270 Homo sapiens miR-1910 stem-loop Proteins 0.000 description 1
• 108091067982 Homo sapiens miR-197 stem-loop Proteins 0.000 description 1
• 108091039001 Homo sapiens miR-1972-1 stem-loop Proteins 0.000 description 1
• 108091033921 Homo sapiens miR-1972-2 stem-loop Proteins 0.000 description 1
• 108091039003 Homo sapiens miR-1976 stem-loop Proteins 0.000 description 1
• 108091067677 Homo sapiens miR-198 stem-loop Proteins 0.000 description 1
• 108091069527 Homo sapiens miR-223 stem-loop Proteins 0.000 description 1
• 108091070371 Homo sapiens miR-25 stem-loop Proteins 0.000 description 1
• 108091065163 Homo sapiens miR-30c-1 stem-loop Proteins 0.000 description 1
• 108091060457 Homo sapiens miR-320b-1 stem-loop Proteins 0.000 description 1
• 108091062096 Homo sapiens miR-320b-2 stem-loop Proteins 0.000 description 1
• 108091060471 Homo sapiens miR-320c-1 stem-loop Proteins 0.000 description 1
• 108091078079 Homo sapiens miR-320c-2 stem-loop Proteins 0.000 description 1
• 108091078081 Homo sapiens miR-320d-1 stem-loop Proteins 0.000 description 1
• 108091078082 Homo sapiens miR-320d-2 stem-loop Proteins 0.000 description 1
• 108091067005 Homo sapiens miR-328 stem-loop Proteins 0.000 description 1
• 108091032109 Homo sapiens miR-423 stem-loop Proteins 0.000 description 1
• 108091032103 Homo sapiens miR-425 stem-loop Proteins 0.000 description 1
• 108091053841 Homo sapiens miR-483 stem-loop Proteins 0.000 description 1
• 108091053854 Homo sapiens miR-484 stem-loop Proteins 0.000 description 1
• 108091053840 Homo sapiens miR-486 stem-loop Proteins 0.000 description 1
• 108091059229 Homo sapiens miR-486-2 stem-loop Proteins 0.000 description 1
• 108091063565 Homo sapiens miR-532 stem-loop Proteins 0.000 description 1
• 108091063808 Homo sapiens miR-574 stem-loop Proteins 0.000 description 1
• 108091061778 Homo sapiens miR-615 stem-loop Proteins 0.000 description 1
• 108091061634 Homo sapiens miR-634 stem-loop Proteins 0.000 description 1
• 108091061623 Homo sapiens miR-636 stem-loop Proteins 0.000 description 1
• 108091086709 Homo sapiens miR-675 stem-loop Proteins 0.000 description 1
• 108091092101 Homo sapiens miR-711 stem-loop Proteins 0.000 description 1
• 108091086454 Homo sapiens miR-744 stem-loop Proteins 0.000 description 1
• 108091062103 Homo sapiens miR-762 stem-loop Proteins 0.000 description 1
• 108091087855 Homo sapiens miR-765 stem-loop Proteins 0.000 description 1
• 108091062099 Homo sapiens miR-766 stem-loop Proteins 0.000 description 1
• 108091086652 Homo sapiens miR-885 stem-loop Proteins 0.000 description 1
• 108091070377 Homo sapiens miR-93 stem-loop Proteins 0.000 description 1
• 238000009015 Human TaqMan MicroRNA Assay kit Methods 0.000 description 1
• 208000023105 Huntington disease Diseases 0.000 description 1
• 208000035154 Hyperesthesia Diseases 0.000 description 1
• 206010020751 Hypersensitivity Diseases 0.000 description 1
• 208000013016 Hypoglycemia Diseases 0.000 description 1
• 206010021143 Hypoxia Diseases 0.000 description 1
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
• 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 1
• 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 1
• 208000000209 Isaacs syndrome Diseases 0.000 description 1
• 201000008645 Joubert syndrome Diseases 0.000 description 1
• 108010092694 L-Selectin Proteins 0.000 description 1
• 102100033467 L-selectin Human genes 0.000 description 1
• 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 1
• 108091007772 MIRLET7C Proteins 0.000 description 1
• 241000124008 Mammalia Species 0.000 description 1
• 102100030412 Matrix metalloproteinase-9 Human genes 0.000 description 1
• 108010015302 Matrix metalloproteinase-9 Proteins 0.000 description 1
• 201000009906 Meningitis Diseases 0.000 description 1
• 102100036834 Metabotropic glutamate receptor 1 Human genes 0.000 description 1
• FQISKWAFAHGMGT-SGJOWKDISA-M Methylprednisolone sodium succinate Chemical compound [Na+].C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)COC(=O)CCC([O-])=O)CC[C@H]21 FQISKWAFAHGMGT-SGJOWKDISA-M 0.000 description 1
• 102000029749 Microtubule Human genes 0.000 description 1
• 108091022875 Microtubule Proteins 0.000 description 1
• 108090001040 Microtubule-associated protein 1B Proteins 0.000 description 1
• 102000004866 Microtubule-associated protein 1B Human genes 0.000 description 1
• 102100021794 Microtubule-associated protein 4 Human genes 0.000 description 1
• 206010049567 Miller Fisher syndrome Diseases 0.000 description 1
• 102100035971 Molybdopterin molybdenumtransferase Human genes 0.000 description 1
• 208000004221 Multiple Trauma Diseases 0.000 description 1
• 208000023637 Multiple injury Diseases 0.000 description 1
• UQOFGTXDASPNLL-XHNCKOQMSA-N Muscarine Chemical compound C[C@@H]1O[C@H](C[N+](C)(C)C)C[C@H]1O UQOFGTXDASPNLL-XHNCKOQMSA-N 0.000 description 1
• 108010008409 Muscarinic M5 Receptor Proteins 0.000 description 1
• 229940121948 Muscarinic receptor antagonist Drugs 0.000 description 1
• FMPNFDSPHNUFOS-UHFFFAOYSA-N N-Methyl-himandravin Natural products C12C(C)OC(=O)C2CC2CCCCC2C1C=CC1CCCC(C)N1C FMPNFDSPHNUFOS-UHFFFAOYSA-N 0.000 description 1
• 229910020700 Na3VO4 Inorganic materials 0.000 description 1
• 238000011887 Necropsy Methods 0.000 description 1
• 208000028389 Nerve injury Diseases 0.000 description 1
• 108010077960 Neurocalcin Proteins 0.000 description 1
• 102100027348 Neurocalcin-delta Human genes 0.000 description 1
• 108010026092 Neuroglobin Proteins 0.000 description 1
• 102000013274 Neuroglobin Human genes 0.000 description 1
• 102000002111 Neuropilin Human genes 0.000 description 1
• 108050009450 Neuropilin Proteins 0.000 description 1
• 206010029350 Neurotoxicity Diseases 0.000 description 1
• 102000019315 Nicotinic acetylcholine receptors Human genes 0.000 description 1
• 108050006807 Nicotinic acetylcholine receptors Proteins 0.000 description 1
• 239000000020 Nitrocellulose Substances 0.000 description 1
• 238000000636 Northern blotting Methods 0.000 description 1
• 108091093105 Nuclear DNA Proteins 0.000 description 1
• 108091005461 Nucleic proteins Proteins 0.000 description 1
• 239000004677 Nylon Substances 0.000 description 1
• 108010038807 Oligopeptides Proteins 0.000 description 1
• 102000015636 Oligopeptides Human genes 0.000 description 1
• 102000002512 Orexin Human genes 0.000 description 1
• 101100131116 Oryza sativa subsp. japonica MPK3 gene Proteins 0.000 description 1
• RSDOPYMFZBJHRL-UHFFFAOYSA-N Oxotremorine Chemical compound O=C1CCCN1CC#CCN1CCCC1 RSDOPYMFZBJHRL-UHFFFAOYSA-N 0.000 description 1
• 101150025562 PCP4 gene Proteins 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 208000002193 Pain Diseases 0.000 description 1
• 101710124239 Poly(A) polymerase Proteins 0.000 description 1
• 239000004743 Polypropylene Substances 0.000 description 1
• 239000004793 Polystyrene Substances 0.000 description 1
• 206010036313 Post-traumatic headache Diseases 0.000 description 1
• 102000011195 Profilin Human genes 0.000 description 1
• 108050001408 Profilin Proteins 0.000 description 1
• 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 description 1
• 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 description 1
• 102100021487 Protein S100-B Human genes 0.000 description 1
• 101710122255 Protein S100-B Proteins 0.000 description 1
• 102000002727 Protein Tyrosine Phosphatase Human genes 0.000 description 1
• 108010007125 Pulmonary Surfactant-Associated Protein C Proteins 0.000 description 1
• 102000007620 Pulmonary Surfactant-Associated Protein C Human genes 0.000 description 1
• 108010005730 R-SNARE Proteins Proteins 0.000 description 1
• 108091034057 RNA (poly(A)) Proteins 0.000 description 1
• 238000011529 RT qPCR Methods 0.000 description 1
• 241000700157 Rattus norvegicus Species 0.000 description 1
• 108091066059 Rattus norvegicus miR-140 stem-loop Proteins 0.000 description 1
• 102100028508 Receptor-type tyrosine-protein phosphatase zeta Human genes 0.000 description 1
• 102000018210 Recoverin Human genes 0.000 description 1
• 108010076570 Recoverin Proteins 0.000 description 1
• 102000007156 Resistin Human genes 0.000 description 1
• 108010047909 Resistin Proteins 0.000 description 1
• 102100040756 Rhodopsin Human genes 0.000 description 1
• 108090000820 Rhodopsin Proteins 0.000 description 1
• 108091028664 Ribonucleotide Proteins 0.000 description 1
• 206010039203 Road traffic accident Diseases 0.000 description 1
• QCHFTSOMWOSFHM-UHFFFAOYSA-N SJ000285536 Natural products C1OC(=O)C(CC)C1CC1=CN=CN1C QCHFTSOMWOSFHM-UHFFFAOYSA-N 0.000 description 1
• 101100276022 Schizosaccharomyces pombe (strain 972 / ATCC 24843) lsk1 gene Proteins 0.000 description 1
• 101100456045 Schizosaccharomyces pombe (strain 972 / ATCC 24843) map3 gene Proteins 0.000 description 1
• 206010039897 Sedation Diseases 0.000 description 1
• 238000012300 Sequence Analysis Methods 0.000 description 1
• 208000002108 Shaken Baby Syndrome Diseases 0.000 description 1
• 238000002105 Southern blotting Methods 0.000 description 1
• 241000194017 Streptococcus Species 0.000 description 1
• 208000032851 Subarachnoid Hemorrhage Diseases 0.000 description 1
• 208000027522 Sydenham chorea Diseases 0.000 description 1
• 102000001435 Synapsin Human genes 0.000 description 1
• 108050009621 Synapsin Proteins 0.000 description 1
• 102000002215 Synaptobrevin Human genes 0.000 description 1
• 102100035604 Synaptopodin Human genes 0.000 description 1
• 101710119889 Synaptopodin Proteins 0.000 description 1
• HATRDXDCPOXQJX-UHFFFAOYSA-N Thapsigargin Natural products CCCCCCCC(=O)OC1C(OC(O)C(=C/C)C)C(=C2C3OC(=O)C(C)(O)C3(O)C(CC(C)(OC(=O)C)C12)OC(=O)CCC)C HATRDXDCPOXQJX-UHFFFAOYSA-N 0.000 description 1
• 241000656145 Thyrsites atun Species 0.000 description 1
• 206010044221 Toxic encephalopathy Diseases 0.000 description 1
• 102100030248 Transcription factor SOX-1 Human genes 0.000 description 1
• 108020004566 Transfer RNA Proteins 0.000 description 1
• 208000032109 Transient ischaemic attack Diseases 0.000 description 1
• 102000003425 Tyrosinase Human genes 0.000 description 1
• 108060008724 Tyrosinase Proteins 0.000 description 1
• 101710186825 Ubiquitin carboxyl-terminal hydrolase isozyme L1 Proteins 0.000 description 1
• 206010045380 Ulnar neuritis Diseases 0.000 description 1
• 101100107916 Xenopus laevis chrm4 gene Proteins 0.000 description 1
• MIFGOLAMNLSLGH-QOKNQOGYSA-N Z-Val-Ala-Asp(OMe)-CH2F Chemical compound COC(=O)C[C@@H](C(=O)CF)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)OCC1=CC=CC=C1 MIFGOLAMNLSLGH-QOKNQOGYSA-N 0.000 description 1
• 101710185494 Zinc finger protein Proteins 0.000 description 1
• 102100023597 Zinc finger protein 816 Human genes 0.000 description 1
• OPQRFPHLZZPCCH-PGMHBOJBSA-N [(z)-[5-chloro-1-[(2,5-dichlorophenyl)methyl]-2-oxoindol-3-ylidene]amino] acetate Chemical compound C12=CC=C(Cl)C=C2C(=N/OC(=O)C)/C(=O)N1CC1=CC(Cl)=CC=C1Cl OPQRFPHLZZPCCH-PGMHBOJBSA-N 0.000 description 1
• 229960003216 aceclidine Drugs 0.000 description 1
• WRJPSSPFHGNBMG-UHFFFAOYSA-N acetic acid 1-azabicyclo[2.2.2]octan-3-yl ester Chemical compound C1CC2C(OC(=O)C)CN1CC2 WRJPSSPFHGNBMG-UHFFFAOYSA-N 0.000 description 1
• 239000003929 acidic solution Substances 0.000 description 1
• 230000036982 action potential Effects 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• 230000006978 adaptation Effects 0.000 description 1
• 238000001261 affinity purification Methods 0.000 description 1
• 208000026935 allergic disease Diseases 0.000 description 1
• 230000007815 allergy Effects 0.000 description 1
• 206010053552 allodynia Diseases 0.000 description 1
• VLSMHEGGTFMBBZ-UHFFFAOYSA-N alpha-Kainic acid Natural products CC(=C)C1CNC(C(O)=O)C1CC(O)=O VLSMHEGGTFMBBZ-UHFFFAOYSA-N 0.000 description 1
• 108090000185 alpha-Synuclein Proteins 0.000 description 1
• XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
• 229910052782 aluminium Inorganic materials 0.000 description 1
• 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
• 102000004111 amphiphysin Human genes 0.000 description 1
• 108090000686 amphiphysin Proteins 0.000 description 1
• 230000003321 amplification Effects 0.000 description 1
• 108010064539 amyloid beta-protein (1-42) Proteins 0.000 description 1
• DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 description 1
• 230000037005 anaesthesia Effects 0.000 description 1
• 210000002551 anterior cerebral artery Anatomy 0.000 description 1
• 230000003172 anti-dna Effects 0.000 description 1
• 230000002927 anti-mitotic effect Effects 0.000 description 1
• 230000001405 anti-neuronal effect Effects 0.000 description 1
• 230000000890 antigenic effect Effects 0.000 description 1
• 238000011948 assay development Methods 0.000 description 1
• 239000012298 atmosphere Substances 0.000 description 1
• 230000004900 autophagic degradation Effects 0.000 description 1
• 230000007845 axonopathy Effects 0.000 description 1
• 229960002170 azathioprine Drugs 0.000 description 1
• LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 description 1
• 210000004227 basal ganglia Anatomy 0.000 description 1
• NZUPCNDJBJXXRF-UHFFFAOYSA-O bethanechol Chemical compound C[N+](C)(C)CC(C)OC(N)=O NZUPCNDJBJXXRF-UHFFFAOYSA-O 0.000 description 1
• 229960000910 bethanechol Drugs 0.000 description 1
• AFYNADDZULBEJA-UHFFFAOYSA-N bicinchoninic acid Chemical compound C1=CC=CC2=NC(C=3C=C(C4=CC=CC=C4N=3)C(=O)O)=CC(C(O)=O)=C21 AFYNADDZULBEJA-UHFFFAOYSA-N 0.000 description 1
• 239000003150 biochemical marker Substances 0.000 description 1
• 230000008512 biological response Effects 0.000 description 1
• 238000009534 blood test Methods 0.000 description 1
• 210000004204 blood vessel Anatomy 0.000 description 1
• 210000000481 breast Anatomy 0.000 description 1
• UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
• 239000007975 buffered saline Substances 0.000 description 1
• 239000006172 buffering agent Substances 0.000 description 1
• 239000000480 calcium channel blocker Substances 0.000 description 1
• 239000000801 calcium channel stimulating agent Substances 0.000 description 1
• 229960004484 carbachol Drugs 0.000 description 1
• AIXAANGOTKPUOY-UHFFFAOYSA-N carbachol Chemical compound [Cl-].C[N+](C)(C)CCOC(N)=O AIXAANGOTKPUOY-UHFFFAOYSA-N 0.000 description 1
• 210000004413 cardiac myocyte Anatomy 0.000 description 1
• 238000012754 cardiac puncture Methods 0.000 description 1
• 210000000269 carotid artery external Anatomy 0.000 description 1
• 210000004004 carotid artery internal Anatomy 0.000 description 1
• 208000003295 carpal tunnel syndrome Diseases 0.000 description 1
• 238000000423 cell based assay Methods 0.000 description 1
• 210000005056 cell body Anatomy 0.000 description 1
• 208000015114 central nervous system disease Diseases 0.000 description 1
• 210000001638 cerebellum Anatomy 0.000 description 1
• 210000004720 cerebrum Anatomy 0.000 description 1
• WUTYZMFRCNBCHQ-PSASIEDQSA-N cevimeline Chemical compound C1S[C@H](C)O[C@]21C(CC1)CCN1C2 WUTYZMFRCNBCHQ-PSASIEDQSA-N 0.000 description 1
• 229960001314 cevimeline Drugs 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• 238000000701 chemical imaging Methods 0.000 description 1
• 239000007795 chemical reaction product Substances 0.000 description 1
• 230000000718 cholinopositive effect Effects 0.000 description 1
• 238000004587 chromatography analysis Methods 0.000 description 1
• 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 1
• 229930193282 clathrin Natural products 0.000 description 1
• 238000010367 cloning Methods 0.000 description 1
• 229960004170 clozapine Drugs 0.000 description 1
• QZUDBNBUXVUHMW-UHFFFAOYSA-N clozapine Chemical compound C1CN(C)CCN1C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12 QZUDBNBUXVUHMW-UHFFFAOYSA-N 0.000 description 1
• 238000007621 cluster analysis Methods 0.000 description 1
• 238000011278 co-treatment Methods 0.000 description 1
• 108010022822 collapsin response mediator protein-2 Proteins 0.000 description 1
• 238000004440 column chromatography Methods 0.000 description 1
• 230000000052 comparative effect Effects 0.000 description 1
• 230000000295 complement effect Effects 0.000 description 1
• 230000006835 compression Effects 0.000 description 1
• 238000007906 compression Methods 0.000 description 1
• 230000001010 compromised effect Effects 0.000 description 1
• 230000009514 concussion Effects 0.000 description 1
• 238000012790 confirmation Methods 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
• 230000036757 core body temperature Effects 0.000 description 1
• 210000000877 corpus callosum Anatomy 0.000 description 1
• 108010034906 cortexin Proteins 0.000 description 1
• 102000009854 cortexin Human genes 0.000 description 1
• 230000009537 cortical lesion Effects 0.000 description 1
• 210000005257 cortical tissue Anatomy 0.000 description 1
• 238000007428 craniotomy Methods 0.000 description 1
• 238000002425 crystallisation Methods 0.000 description 1
• 230000008025 crystallization Effects 0.000 description 1
• 210000004748 cultured cell Anatomy 0.000 description 1
• 230000001186 cumulative effect Effects 0.000 description 1
• 210000004292 cytoskeleton Anatomy 0.000 description 1
• 230000034994 death Effects 0.000 description 1
• 230000006735 deficit Effects 0.000 description 1
• 230000007850 degeneration Effects 0.000 description 1
• 230000003412 degenerative effect Effects 0.000 description 1
• 210000001787 dendrite Anatomy 0.000 description 1
• 230000030609 dephosphorylation Effects 0.000 description 1
• 238000006209 dephosphorylation reaction Methods 0.000 description 1
• 206010012601 diabetes mellitus Diseases 0.000 description 1
• 238000012774 diagnostic algorithm Methods 0.000 description 1
• 238000002405 diagnostic procedure Methods 0.000 description 1
• CURUTKGFNZGFSE-UHFFFAOYSA-N dicyclomine Chemical compound C1CCCCC1C1(C(=O)OCCN(CC)CC)CCCCC1 CURUTKGFNZGFSE-UHFFFAOYSA-N 0.000 description 1
• 229960002777 dicycloverine Drugs 0.000 description 1
• 230000004069 differentiation Effects 0.000 description 1
• 230000001079 digestive effect Effects 0.000 description 1
• 239000012470 diluted sample Substances 0.000 description 1
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
• 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
• KAKKHKRHCKCAGH-UHFFFAOYSA-L disodium;(4-nitrophenyl) phosphate;hexahydrate Chemical compound O.O.O.O.O.O.[Na+].[Na+].[O-][N+](=O)C1=CC=C(OP([O-])([O-])=O)C=C1 KAKKHKRHCKCAGH-UHFFFAOYSA-L 0.000 description 1
• 208000035475 disorder Diseases 0.000 description 1
• 101150069842 dlg4 gene Proteins 0.000 description 1
• 238000007876 drug discovery Methods 0.000 description 1
• 210000001951 dura mater Anatomy 0.000 description 1
• 239000012636 effector Substances 0.000 description 1
• 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
• 201000002491 encephalomyelitis Diseases 0.000 description 1
• 238000005516 engineering process Methods 0.000 description 1
• UGYPGJCVNPPUPE-UHFFFAOYSA-N enpiperate Chemical compound C1CN(C)CCC1OC(=O)C(O)(C=1C=CC=CC=1)C1=CC=CC=C1 UGYPGJCVNPPUPE-UHFFFAOYSA-N 0.000 description 1
• 238000001952 enzyme assay Methods 0.000 description 1
• DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
• 230000005284 excitation Effects 0.000 description 1
• 208000012997 experimental autoimmune encephalomyelitis Diseases 0.000 description 1
• 239000000284 extract Substances 0.000 description 1
• 210000003608 fece Anatomy 0.000 description 1
• 239000012091 fetal bovine serum Substances 0.000 description 1
• 230000001605 fetal effect Effects 0.000 description 1
• 239000007850 fluorescent dye Substances 0.000 description 1
• 210000001652 frontal lobe Anatomy 0.000 description 1
• 230000005021 gait Effects 0.000 description 1
• 238000001502 gel electrophoresis Methods 0.000 description 1
• 108010024999 gephyrin Proteins 0.000 description 1
• MNQZXJOMYWMBOU-UHFFFAOYSA-N glyceraldehyde Chemical class OCC(O)C=O MNQZXJOMYWMBOU-UHFFFAOYSA-N 0.000 description 1
• 229910052737 gold Inorganic materials 0.000 description 1
• 239000010931 gold Substances 0.000 description 1
• 239000008187 granular material Substances 0.000 description 1
• 210000004884 grey matter Anatomy 0.000 description 1
• 210000002216 heart Anatomy 0.000 description 1
• 210000003494 hepatocyte Anatomy 0.000 description 1
• FMPNFDSPHNUFOS-LPJDIUFZSA-N himbacine Chemical compound C(/[C@@H]1[C@H]2CCCC[C@@H]2C[C@@H]2C(=O)O[C@H]([C@H]12)C)=C\[C@H]1CCC[C@H](C)N1C FMPNFDSPHNUFOS-LPJDIUFZSA-N 0.000 description 1
• 210000004295 hippocampal neuron Anatomy 0.000 description 1
• 208000003906 hydrocephalus Diseases 0.000 description 1
• MHAJPDPJQMAIIY-UHFFFAOYSA-N hydrogen peroxide Substances OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
• 230000007954 hypoxia Effects 0.000 description 1
• 238000010191 image analysis Methods 0.000 description 1
• 230000028993 immune response Effects 0.000 description 1
• 238000010166 immunofluorescence Methods 0.000 description 1
• 230000002163 immunogen Effects 0.000 description 1
• 230000002055 immunohistochemical effect Effects 0.000 description 1
• 238000003364 immunohistochemistry Methods 0.000 description 1
• 239000002955 immunomodulating agent Substances 0.000 description 1
• 229940121354 immunomodulator Drugs 0.000 description 1
• 239000003547 immunosorbent Substances 0.000 description 1
• 230000003116 impacting effect Effects 0.000 description 1
• 230000001976 improved effect Effects 0.000 description 1
• 238000005462 in vivo assay Methods 0.000 description 1
• 238000012750 in vivo screening Methods 0.000 description 1
• 210000004283 incisor Anatomy 0.000 description 1
• 229930005303 indole alkaloid Natural products 0.000 description 1
• 150000002475 indoles Chemical class 0.000 description 1
• 230000006698 induction Effects 0.000 description 1
• 239000012678 infectious agent Substances 0.000 description 1
• 230000002458 infectious effect Effects 0.000 description 1
• 230000000266 injurious effect Effects 0.000 description 1
• 229940047124 interferons Drugs 0.000 description 1
• 210000000936 intestine Anatomy 0.000 description 1
• 210000004020 intracellular membrane Anatomy 0.000 description 1
• 238000007917 intracranial administration Methods 0.000 description 1
• 201000009941 intracranial hypertension Diseases 0.000 description 1
• 239000007927 intramuscular injection Substances 0.000 description 1
• 238000010255 intramuscular injection Methods 0.000 description 1
• 239000007928 intraperitoneal injection Substances 0.000 description 1
• 238000007913 intrathecal administration Methods 0.000 description 1
• 238000005342 ion exchange Methods 0.000 description 1
• 238000004255 ion exchange chromatography Methods 0.000 description 1
• 208000028867 ischemia Diseases 0.000 description 1
• YWXYYJSYQOXTPL-SLPGGIOYSA-N isosorbide mononitrate Chemical compound [O-][N+](=O)O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 YWXYYJSYQOXTPL-SLPGGIOYSA-N 0.000 description 1
• VLSMHEGGTFMBBZ-OOZYFLPDSA-N kainic acid Chemical compound CC(=C)[C@H]1CN[C@H](C(O)=O)[C@H]1CC(O)=O VLSMHEGGTFMBBZ-OOZYFLPDSA-N 0.000 description 1
• 229950006874 kainic acid Drugs 0.000 description 1
• 210000003734 kidney Anatomy 0.000 description 1
• 210000003292 kidney cell Anatomy 0.000 description 1
• GKWPCEFFIHSJOE-UHFFFAOYSA-N laquinimod Chemical compound OC=1C2=C(Cl)C=CC=C2N(C)C(=O)C=1C(=O)N(CC)C1=CC=CC=C1 GKWPCEFFIHSJOE-UHFFFAOYSA-N 0.000 description 1
• 229960004577 laquinimod Drugs 0.000 description 1
• 230000001418 larval effect Effects 0.000 description 1
• 150000002611 lead compounds Chemical class 0.000 description 1
• 230000003902 lesion Effects 0.000 description 1
• 239000003446 ligand Substances 0.000 description 1
• 208000010325 limbic encephalitis Diseases 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 239000007788 liquid Substances 0.000 description 1
• 238000004811 liquid chromatography Methods 0.000 description 1
• 239000012160 loading buffer Substances 0.000 description 1
• 230000006742 locomotor activity Effects 0.000 description 1
• 238000009593 lumbar puncture Methods 0.000 description 1
• 210000004072 lung Anatomy 0.000 description 1
• 206010025135 lupus erythematosus Diseases 0.000 description 1
• 239000012139 lysis buffer Substances 0.000 description 1
• 238000010841 mRNA extraction Methods 0.000 description 1
• 229920002521 macromolecule Polymers 0.000 description 1
• 239000006249 magnetic particle Substances 0.000 description 1
• 238000002595 magnetic resonance imaging Methods 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 230000036244 malformation Effects 0.000 description 1
• 230000008774 maternal effect Effects 0.000 description 1
• 239000002609 medium Substances 0.000 description 1
• 206010027175 memory impairment Diseases 0.000 description 1
• 108010014719 metabotropic glutamate receptor type 1 Proteins 0.000 description 1
• NZWOPGCLSHLLPA-UHFFFAOYSA-N methacholine Chemical compound C[N+](C)(C)CC(C)OC(C)=O NZWOPGCLSHLLPA-UHFFFAOYSA-N 0.000 description 1
• 229960002329 methacholine Drugs 0.000 description 1
• 229960004584 methylprednisolone Drugs 0.000 description 1
• 108091056924 miR-124 stem-loop Proteins 0.000 description 1
• 230000004089 microcirculation Effects 0.000 description 1
• 238000002406 microsurgery Methods 0.000 description 1
• 210000004688 microtubule Anatomy 0.000 description 1
• 210000003657 middle cerebral artery Anatomy 0.000 description 1
• 230000001617 migratory effect Effects 0.000 description 1
• YMMXHEYLRHNXAB-RMKNXTFCSA-N milameline Chemical compound CO\N=C\C1=CCCN(C)C1 YMMXHEYLRHNXAB-RMKNXTFCSA-N 0.000 description 1
• 229950004373 milameline Drugs 0.000 description 1
• KKZJGLLVHKMTCM-UHFFFAOYSA-N mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 description 1
• 229960001156 mitoxantrone Drugs 0.000 description 1
• 230000009526 moderate injury Effects 0.000 description 1
• 238000010369 molecular cloning Methods 0.000 description 1
• 238000012544 monitoring process Methods 0.000 description 1
• 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
• 239000004570 mortar (masonry) Substances 0.000 description 1
• 230000004973 motor coordination Effects 0.000 description 1
• 238000010172 mouse model Methods 0.000 description 1
• 239000003149 muscarinic antagonist Substances 0.000 description 1
• 206010028417 myasthenia gravis Diseases 0.000 description 1
• 210000000107 myocyte Anatomy 0.000 description 1
• 230000001338 necrotic effect Effects 0.000 description 1
• 239000013642 negative control Substances 0.000 description 1
• 230000008764 nerve damage Effects 0.000 description 1
• 210000000944 nerve tissue Anatomy 0.000 description 1
• 210000002241 neurite Anatomy 0.000 description 1
• 230000000626 neurodegenerative effect Effects 0.000 description 1
• 208000008795 neuromyelitis optica Diseases 0.000 description 1
• 230000016273 neuron death Effects 0.000 description 1
• 230000009223 neuronal apoptosis Effects 0.000 description 1
• 230000002981 neuropathic effect Effects 0.000 description 1
• 230000007171 neuropathology Effects 0.000 description 1
• 230000004112 neuroprotection Effects 0.000 description 1
• 231100000228 neurotoxicity Toxicity 0.000 description 1
• 230000007135 neurotoxicity Effects 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• 229960002715 nicotine Drugs 0.000 description 1
• SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
• JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 1
• 229920001220 nitrocellulos Polymers 0.000 description 1
• 229910052757 nitrogen Inorganic materials 0.000 description 1
• 108091027963 non-coding RNA Proteins 0.000 description 1
• 102000042567 non-coding RNA Human genes 0.000 description 1
• 238000003199 nucleic acid amplification method Methods 0.000 description 1
• 229920001778 nylon Polymers 0.000 description 1
• 208000028780 ocular motility disease Diseases 0.000 description 1
• KVWDHTXUZHCGIO-UHFFFAOYSA-N olanzapine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2NC2=C1C=C(C)S2 KVWDHTXUZHCGIO-UHFFFAOYSA-N 0.000 description 1
• 229960005017 olanzapine Drugs 0.000 description 1
• 229940124276 oligodeoxyribonucleotide Drugs 0.000 description 1
• 238000012346 open field test Methods 0.000 description 1
• 108060005714 orexin Proteins 0.000 description 1
• 230000002018 overexpression Effects 0.000 description 1
• 230000036407 pain Effects 0.000 description 1
• 229940127255 pan-caspase inhibitor Drugs 0.000 description 1
• 230000009745 pathological pathway Effects 0.000 description 1
• 208000027232 peripheral nervous system disease Diseases 0.000 description 1
• 230000035699 permeability Effects 0.000 description 1
• 102000013415 peroxidase activity proteins Human genes 0.000 description 1
• 108040007629 peroxidase activity proteins Proteins 0.000 description 1
• 235000020030 perry Nutrition 0.000 description 1
• 230000002085 persistent effect Effects 0.000 description 1
• 238000002823 phage display Methods 0.000 description 1
• 238000002135 phase contrast microscopy Methods 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 229960001416 pilocarpine Drugs 0.000 description 1
• RMHMFHUVIITRHF-UHFFFAOYSA-N pirenzepine Chemical compound C1CN(C)CCN1CC(=O)N1C2=NC=CC=C2NC(=O)C2=CC=CC=C21 RMHMFHUVIITRHF-UHFFFAOYSA-N 0.000 description 1
• 229960004633 pirenzepine Drugs 0.000 description 1
• 239000004033 plastic Substances 0.000 description 1
• 229920003023 plastic Polymers 0.000 description 1
• 229920000729 poly(L-lysine) polymer Polymers 0.000 description 1
• 229920000642 polymer Polymers 0.000 description 1
• 229920001155 polypropylene Polymers 0.000 description 1
• 229920002223 polystyrene Polymers 0.000 description 1
• 239000013641 positive control Substances 0.000 description 1
• 238000002600 positron emission tomography Methods 0.000 description 1
• 230000001242 postsynaptic effect Effects 0.000 description 1
• 238000011533 pre-incubation Methods 0.000 description 1
• 239000002243 precursor Substances 0.000 description 1
• 230000003518 presynaptic effect Effects 0.000 description 1
• 230000000861 pro-apoptotic effect Effects 0.000 description 1
• 238000012545 processing Methods 0.000 description 1
• 238000004393 prognosis Methods 0.000 description 1
• 208000037821 progressive disease Diseases 0.000 description 1
• 230000000750 progressive effect Effects 0.000 description 1
• 230000002062 proliferating effect Effects 0.000 description 1
• 230000035755 proliferation Effects 0.000 description 1
• 230000002035 prolonged effect Effects 0.000 description 1
• XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 1
• UQOQENZZLBSFKO-POPPZSFYSA-N prostaglandin J2 Chemical compound CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](C\C=C/CCCC(O)=O)C=CC1=O UQOQENZZLBSFKO-POPPZSFYSA-N 0.000 description 1
• 235000019833 protease Nutrition 0.000 description 1
• 230000004853 protein function Effects 0.000 description 1
• 239000003531 protein hydrolysate Substances 0.000 description 1
• 238000001243 protein synthesis Methods 0.000 description 1
• 108020000494 protein-tyrosine phosphatase Proteins 0.000 description 1
• 230000006337 proteolytic cleavage Effects 0.000 description 1
• 238000000746 purification Methods 0.000 description 1
• NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 1
• 238000011158 quantitative evaluation Methods 0.000 description 1
• 230000002285 radioactive effect Effects 0.000 description 1
• 230000009257 reactivity Effects 0.000 description 1
• 229940044551 receptor antagonist Drugs 0.000 description 1
• 239000002464 receptor antagonist Substances 0.000 description 1
• 229940075993 receptor modulator Drugs 0.000 description 1
• 230000011514 reflex Effects 0.000 description 1
• 230000001105 regulatory effect Effects 0.000 description 1
• 230000010410 reperfusion Effects 0.000 description 1
• 230000004043 responsiveness Effects 0.000 description 1
• 210000001525 retina Anatomy 0.000 description 1
• 238000010839 reverse transcription Methods 0.000 description 1
• 239000002336 ribonucleotide Substances 0.000 description 1
• 125000002652 ribonucleotide group Chemical group 0.000 description 1
• XPYLKZZOBVLVHB-QDKIRNHSSA-N rociverine Chemical compound CCN(CC)CC(C)OC(=O)[C@H]1CCCC[C@]1(O)C1CCCCC1 XPYLKZZOBVLVHB-QDKIRNHSSA-N 0.000 description 1
• 229960001538 rociverine Drugs 0.000 description 1
• 150000003839 salts Chemical class 0.000 description 1
• 210000003497 sciatic nerve Anatomy 0.000 description 1
• 230000036280 sedation Effects 0.000 description 1
• 210000000582 semen Anatomy 0.000 description 1
• 230000001953 sensory effect Effects 0.000 description 1
• 210000002265 sensory receptor cell Anatomy 0.000 description 1
• 239000002356 single layer Substances 0.000 description 1
• 210000002027 skeletal muscle Anatomy 0.000 description 1
• 210000003491 skin Anatomy 0.000 description 1
• 239000002002 slurry Substances 0.000 description 1
• 235000017557 sodium bicarbonate Nutrition 0.000 description 1
• 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
• 210000004872 soft tissue Anatomy 0.000 description 1
• 239000007790 solid phase Substances 0.000 description 1
• 230000009870 specific binding Effects 0.000 description 1
• 238000011895 specific detection Methods 0.000 description 1
• 238000002798 spectrophotometry method Methods 0.000 description 1
• 238000002693 spinal anesthesia Methods 0.000 description 1
• 210000000278 spinal cord Anatomy 0.000 description 1
• 210000000952 spleen Anatomy 0.000 description 1
• 230000002269 spontaneous effect Effects 0.000 description 1
• 238000012453 sprague-dawley rat model Methods 0.000 description 1
• 230000006641 stabilisation Effects 0.000 description 1
• 238000011105 stabilization Methods 0.000 description 1
• 210000000130 stem cell Anatomy 0.000 description 1
• 210000002784 stomach Anatomy 0.000 description 1
• 238000003860 storage Methods 0.000 description 1
• 201000009032 substance abuse Diseases 0.000 description 1
• 231100000736 substance abuse Toxicity 0.000 description 1
• 208000011117 substance-related disease Diseases 0.000 description 1
• 239000006228 supernatant Substances 0.000 description 1
• 239000013589 supplement Substances 0.000 description 1
• 208000024891 symptom Diseases 0.000 description 1
• 230000000946 synaptic effect Effects 0.000 description 1
• 208000011580 syndromic disease Diseases 0.000 description 1
• 230000002195 synergetic effect Effects 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
• 238000004885 tandem mass spectrometry Methods 0.000 description 1
• IXFPJGBNCFXKPI-FSIHEZPISA-N thapsigargin Chemical compound CCCC(=O)O[C@H]1C[C@](C)(OC(C)=O)[C@H]2[C@H](OC(=O)CCCCCCC)[C@@H](OC(=O)C(\C)=C/C)C(C)=C2[C@@H]2OC(=O)[C@@](C)(O)[C@]21O IXFPJGBNCFXKPI-FSIHEZPISA-N 0.000 description 1
• 229940124597 therapeutic agent Drugs 0.000 description 1
• 208000037816 tissue injury Diseases 0.000 description 1
• OOGJQPCLVADCPB-HXUWFJFHSA-N tolterodine Chemical compound C1([C@@H](CCN(C(C)C)C(C)C)C=2C(=CC=C(C)C=2)O)=CC=CC=C1 OOGJQPCLVADCPB-HXUWFJFHSA-N 0.000 description 1
• 229960004045 tolterodine Drugs 0.000 description 1
• 230000009261 transgenic effect Effects 0.000 description 1
• 201000010875 transient cerebral ischemia Diseases 0.000 description 1
• 230000014616 translation Effects 0.000 description 1
• 208000018726 traumatic encephalopathy Diseases 0.000 description 1
• 230000003144 traumatizing effect Effects 0.000 description 1
• VVLMSCJCXMBGDI-UHFFFAOYSA-M trimethyl-[4-(2-oxopyrrolidin-1-yl)but-2-ynyl]azanium;iodide Chemical compound [I-].C[N+](C)(C)CC#CCN1CCCC1=O VVLMSCJCXMBGDI-UHFFFAOYSA-M 0.000 description 1
• IHIXIJGXTJIKRB-UHFFFAOYSA-N trisodium vanadate Chemical compound [Na+].[Na+].[Na+].[O-][V]([O-])([O-])=O IHIXIJGXTJIKRB-UHFFFAOYSA-N 0.000 description 1
• 208000036722 ulnar neuropathy Diseases 0.000 description 1
• 230000003827 upregulation Effects 0.000 description 1
• 238000011144 upstream manufacturing Methods 0.000 description 1
• BDIAUFOIMFAIPU-UHFFFAOYSA-N valepotriate Natural products CC(C)CC(=O)OC1C=C(C(=COC2OC(=O)CC(C)C)COC(C)=O)C2C11CO1 BDIAUFOIMFAIPU-UHFFFAOYSA-N 0.000 description 1
• 230000002792 vascular Effects 0.000 description 1
• 210000003462 vein Anatomy 0.000 description 1
• 102000038650 voltage-gated calcium channel activity Human genes 0.000 description 1
• 108091023044 voltage-gated calcium channel activity Proteins 0.000 description 1
• JOLJIIDDOBNFHW-UHFFFAOYSA-N xanomeline Chemical compound CCCCCCOC1=NSN=C1C1=CCCN(C)C1 JOLJIIDDOBNFHW-UHFFFAOYSA-N 0.000 description 1
• 229950006755 xanomeline Drugs 0.000 description 1